Protecting the public's health: Critical functions of the section 317 immunization program-A report of the national vaccine advisory committee

Public Health Reports

Volumn 128, Issue 2, 2013, Pages 78-95

  Sachs, Jody ^a  

^a not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PCV 7 VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACUTE GASTROENTERITIS; ADVISORY COMMITTEE; ASEPTIC MENINGITIS; BUDGET; CHICKENPOX; CHILDHOOD DISEASE; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EMERGENCY HEALTH SERVICE; EPIDEMIC; EVIDENCE BASED PRACTICE; FUNDING; HAEMOPHILUS INFECTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTUSSUSCEPTION; LICENSING; MEASLES; NOTE; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SMALLPOX; TETANUS; VACCINATION;

EID: 84886998345     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491312800203     Document Type: Note

References (39)

1. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92-9.
2. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49(RR-9):1-38.
3. Notice to readers: decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep 2001;50(36):783-4.
4. Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage-Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2001;50(50):1140-2.
5. Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep 2004;53(36):851-2.
6. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41.
7. Zhou F, Shefer A, Wenger J, Messonnier M, Wang LY, Lopez A, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Abstract presented at the Pediatric Academic Societies' Annual Meeting; 2012 Apr 28-May 1; Boston.
8. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010;59(9):258-61.
9. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged #59 months-selected U.S. regions, 2010-2011 [published erratum appears in MMWR Morb Mortal Wkly Rep 2011;60(44):1530]. MMWR Morb Mortal Wkly Rep 2011;60(43):1477-81.
10. Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 2012; 61(21):394-5.
11. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298:2155-63.
12. Pub. L. No. 111-48, 124 Stat. 119 (2010).
13. Pub. L. No. 111-52, 124 Stat. 1029 (2010).
14. Title XXI of the Public Health Service Act (Pub. L. No. 99-660) (§2105) (42 U.S.C. 300aa-5).
15. Pub. L. No. 67-13, 42 Stat 20, 31 U.S.C. 11.
16. Shen AK, Spinner JR, Salmon DA, Gellin BG. Strengthening the U.S. vaccine and immunization enterprise: the role of the National Vaccine Advisory Committee. Public Health Rep 2011;126:4-8.
17. Rein DB, Honeycutt AA, Rojas-Smith L, Hersey C. Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage. Am J Public Health 2006;96:1548-53.
18. Department of Health and Human Services (US). Recommended preventive services [cited 2012 Oct 25]. Available from: URL: http://www.healthcare.gov/law/resources/regulations/prevention /recommendations.html
19. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49(RR-5):1-22.
20. Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics 2012;129:1056-63.
21. Centers for Disease Control and Prevention (US). Vaccines for Children Program (VFC) [cited 2012 Aug 13]. Available from: URL: http://www.cdc.gov/vaccines/programs/vfc/index.html
22. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2005. MMWR Morb Mortal Wkly Rep 2006;55(36):988-93.
23. Guide to Community Preventive Services. Vaccinations to prevent diseases: universally recommended vaccinations [cited 2012 Oct 25]. Available from: URL: http://www.thecommunityguide.org/vaccines /universally/index.html
24. National Vaccine Advisory Committee. A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee. Public Health Rep 2012;127 Suppl 1:1-42.
25. California Department of Public Health. Vaccine storage and handling [cited 2012 Oct 25]. Available from: URL: http://www.cdph.ca.gov/programs/immunize/Pages/VaccineStorageandHandling. aspx
26. Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 2001;20:410-6.
27. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48(27): 577-81.
28. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999;48(43):1007.
29. Department of Health and Human Services (US). Healthy People 2020 [cited 2012 Sep 21]. Available from: URL: http://www. healthypeople.gov/2020/default.aspx
30. Centers for Disease Control and Prevention (US). Transmission of measles [cited 2012 Aug 13]. Available from: URL: http://www.cdc.gov/measles/about/transmission.html
31. Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004;189 Suppl 1:S43-7.
32. Parker Fiebelkorn A, Redd SB, Gallagher K, Rota PA, Rota J, Bellini W, et al. Measles in the United States during the postelimination era. J Infect Dis 2010;202:1520-8.
33. Measles-United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61(15):253-7.
34. California Department of Public Health. Pertussis (whooping cough) [cited 2012 Sep 16]. Available from: URL: http://www.cdph.ca.gov/HealthInfo/discond/Pages/Pertussis.aspx
35. Washington State Department of Health. Pertussis epidemic 2012 [cited 2012 Aug 21]. Available from: URL: http://www.doh.wa.gov /YouandYourFamily/IllnessandDisease/WhoopingCough.aspx
36. Centers for Disease Control and Prevention (US). Pertussis (whooping cough): outbreaks [cited 2012 Sep 15]. Available from: URL: http://www.cdc.gov/pertussis/outbreaks.html
37. Centers for Disease Control and Prevention (US). Vaccines & immunizations: publications: ACIP recommendations [cited 2012 Sep 15]. Available from: URL: http://www.cdc.gov/vaccines/pubs /ACIP-list.htm#tdappreg
38. Centers for Disease Control and Prevention (US). Vaccines and preventable diseases: current vaccine shortages & delays [cited 2012 Sep 18]. Available from: URL: http://www.cdc.gov/vaccines /vac-gen/shortages/default.htm#note1
39. Congress of the United States Congressional Budget Office (US). Estimates for the insurance coverage provisions of the Affordable Care Act updated for the recent Supreme Court decision [cited 2012 Oct 25]. Available from: URL: http://www.cbo.gov /publication/43472